Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma

Oral Oncology

Volumn 43, Issue 5, 2007, Pages 455-462

  Kondoh, Nobuo ^a   Ohkura, Shuri ^a   Arai, Masaaki ^a   Hada, Akiyuki ^a   Ishikawa, Toshio ^b   Yamazaki, Yutaka ^c   Shindoh, Masanobu ^c   Takahashi, Masayuki ^a   Kitagawa, Yoshimasa ^c   Matsubara, Osamu ^a   Yamamoto, Mikio ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b ISHIHARA SANGYO KAISHA LTD   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Gene expression profiling; Head and neck oral cancer; Leukoplakia; Microarray; Quantitative reverse transcription PCR

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; DNA MICROARRAY; DOWN REGULATION; DYSPLASIA; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; MARKER GENE; NUCLEOTIDE SEQUENCE; PRECANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 34147169467     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.04.012     Document Type: Article

References (27)

1. Lopez M., Aguirre J.M., Cuevas N., Anzola M., Videgain J., Aguirregaviria J., Castro A., and de Pancorbo M.M. Gene promoter hypermethylation in oral rinses of leukoplakia patients - a diagnostic and/or prognostic tool?. Eur J Cancer 39 (2003) 2306-2309
2. Bloor B.K., Seddon S.V., and Morgan P.R. Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncol 37 (2001) 251-261
3. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
4. Ohkura S., Kondoh N., Hada A., Arai M., Yamazaki Y., Sindoh M., et al. Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol 41 (2005) 607-613
5. Schmalbach C.E., Chepeha D.B., Giordano T.J., Rubin M.A., Teknos T.N., Bradford C.R., et al. molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arc Otolaryngol Head Neck Surg 130 (2004) 295-302
6. Carinci F., Lo Muzio L., Piattelli A., Rubini C., Palmieri A., Stabellini G., et al. Genetic portrait of mild and severe lingual dysplasia. Oral Oncol 41 (2005) 365-374
7. Ginos M.A., Page G.P., Michalowicz B.S., Patel L.J., Volker S.E., Pambuccian S.E., et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64 (2004) 55-63
8. Whipple M.E., Mendez E., Farwell D.G., Agoff S.N., and Chen C. A genomic predictor of oral squamous cell carcinoma. The Laryngoscope 114 (2004) 1354-1364
9. Roepman P., Weesels L.F.A., Kettelarij N., Kemmeren P., Miles A.J., Lijinzaad P., et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinoma. Nature Genet 37 2 (2005) 182-186
10. Iizuka N., Oka M., Yamada-Okabe H., Mori N., Tamesa T., Okada T., et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62 14 (2002) 3939-3944
11. Ramaswamy S., Tamayo P., Rifkin R., Mukherjee S., Yeang C.-H., Angelo M., et al. Multiclass cancer diagnosis using tumor gene expression signature. Proc Natl Acad Sci USA 98 (2001) 15149-15154
12. Arai M., Kondoh N., Imazeki N., Hada A., Hatsuse K., Kimura F., et al. Transformation-associated gene regulation by ATF6 during hepatocarcinogenesis. FEBS Lett 580 (2006) 184-190
13. Fisher N.A. The use of multiple measurements in taxonomic problems. Ann Eugen 7 Part II (1936) 179-188
14. Goldberg D.E. Genetic algorithm in search, optimization and machine learning (1989), Addison-Wesley, Reading (MA) p. 1-26
15. Chen B.S., Wang M.R., and Xu X. Transglutaminase-3, an esophageal cancer-related gene. Int J Cancer 88 6 (2000) 862-865
16. Contzler R., Favre B., Huber M., and Hohl D. Cornulin, a new member of the "Fused gene" family, is expressed during epidermal differentiation. J Invest Dermatol 124 (2005) 990-997
17. Imai F.L., Uzawa K., Nimura Y., Moriya T., Imai M.A., Shiiba M., et al. Chromosome 1 open reading frame 10 (C1orf10) gene is frequently down-regulated and inhibits cell proliferation in oral squamous cell carcinoma. Int J Biochem Cell Biol 37 (2005) 1641-1655
18. Fan C., Sheu D., Fan H., Hsu K., Allen Chang C., and Chan E. Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas. Cancer Lett 165 (2001) 63-69
19. Levedakou E.N., Strohmeyer T.G., Effert P.J., and Liu E.T. Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer 52 (1992) 534-537
20. Chen L., O'Bryan J.P., Smith H.S., and Liu E. Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization. Oncogene 5 (1990) 1391-1395
21. Catherino W.H., Leppert P.C., Stenmark M.H., Payson M., Potlog-Nahari C., Nieman L.K., et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chrom. Cancer 40 (2004) 204-217
22. Milde-Langosch K., Kappes H., Riethdorf S., Loning T., and Bamberger A.M. FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas. Breast Cancer Res Treat 77 (2003) 265-275
23. Patel V., Aldridge K., Ensley J.F., Odell E., Boyd A., Jones J., et al. Laminin-gamma 2 overexpression in head-and-necksquamous cell carcinoma. Int J Cancer 99 (2002) 583-588
24. Rossmanith W., Chabicovsky M., Grasl-Kraupp B., Peter B., Schausberger E., and Schulte-Hermann R. Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control. Mol Carcinog 35 (2002) 1-5
25. Stove C., Vanrobaeys F., Devreese B., Van Beeumen J., Mareel M., and Bracke M. Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition. Oncogene 23 (2004) 5330-5339
26. Goldberg-Bittman L., Neumark E., Sagi-Assif O., Azenshtein E., Meshel T., Witz I.P., et al. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett 92 (2004) 171-178
27. Hiroi M., and Ohmori Y. Constitutive nuclear factor kappa B activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines. Biochem J 376 (2003) 393-402